Cargando…
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study
AIM OF THE STUDY: This multicentre study aimed to examine the actual risk for drug-drug interactions in a cohort of Polish patients, and their impact on antiviral therapy. MATERIAL AND METHODS: Concomitant medications were analyzed in hepatitis C virus (HCV)-infected patients treated with still valu...
Autores principales: | Simon, Krzysztof Adam, Flisiak, Robert, Łapiński, Tadeusz Wojciech, Janczewska, Ewa, Wawrzynowicz-Syczewska, Marta, Jaroszewicz, Jerzy, Zarębska-Michaluk, Dorota, Nazzal, Khalil, Bolewska, Beata, Białkowska, Jolanta, Berak, Hanna, Fleischer-Stępniewska, Katarzyna, Tomasiewicz, Krzysztof, Karwowska, Kornelia, Rostkowska, Karolina Anna, Piekarska, Anna, Tronina, Olga, Madej, Grzegorz, Garlicki, Aleksander, Łucejko, Mariusz, Pisula, Arkadiusz, Karpińska, Ewa, Kryczka, Wiesław, Wiercińska-Drapało, Alicja, Mozer-Lisewska, Iwona, Jabłkowski, Maciej Stanisław, Horban, Andrzej, Knysz, Brygida, Tudrujek, Magdalena, Halota, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781817/ https://www.ncbi.nlm.nih.gov/pubmed/31598558 http://dx.doi.org/10.5114/ceh.2019.87634 |
Ejemplares similares
-
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
por: Janczewska, Ewa, et al.
Publicado: (2018) -
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
por: Bernstein, David E., et al.
Publicado: (2018) -
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
por: Forns, Xavier, et al.
Publicado: (2015) -
Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients
por: Loo, Nicole, et al.
Publicado: (2019) -
Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT‐450, Ombitasvir, and Dasabuvir
por: Badri, P., et al.
Publicado: (2015)